COLL vs VICI · P/E 17, rev $181.9M vs P/E 9.3, rev $3.85B
Collegium Pharmaceutical Inc (COLL) versus VICI Properties Inc (VICI) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
VICI Properties Inc (VICI) is a reit - diversified company listed on NYSE.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported VICI revenue for 2024-12-31 was $3.85B. Net income was $2.72B. Revenue was up 6.6% from 2023-12-31 to 2024-12-31. VICI currently screens at market cap $29.32B and trailing P/E 9.3.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. VICI currently screens at market cap $29.32B and trailing P/E 9.3.
Not investment advice. Open the COLL and VICI stock pages for the full models.
Not investment advice.